Silverarc Capital Management, LLC Horizon Therapeutics Public LTD CO Transaction History

Silverarc Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $806,265 - $1.47 Million	12,923 Added 127.56%	23,054 $2.62 Million
Q3 2022 Oct 28, 2022	SELL	$58.92 - $84.67 $3.66 Million - $5.25 Million	-62,056 Reduced 85.97%	10,131 $627,000
Q2 2022 Jul 25, 2022	BUY	$79.4 - $116.36 $376,753 - $552,128	4,745 Added 7.04%	72,187 $5.76 Million
Q1 2022 May 13, 2022	BUY	$86.42 - $109.81 $496,223 - $630,529	5,742 Added 9.31%	67,442 $7.1 Million
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $909,807 - $1.11 Million	9,231 Added 17.59%	61,700 $6.65 Million

Q3 2021 Nov 15, 2021	BUY	$91.91 - $110.37 $223,708 - $268,640	2,434 Added 4.86%	52,469 $5.75 Million
Q2 2021 Aug 16, 2021	BUY	$86.24 - $95.92 $134,448 - $149,539	1,559 Added 3.22%	50,035 $4.69 Million
Q1 2021 May 18, 2021	BUY	$71.83 - $95.48 $1.33 Million - $1.76 Million	18,476 Added 61.59%	48,476 $4.46 Million
Q4 2020 Feb 16, 2021	BUY	$67.0 - $84.39 $2.01 Million - $2.53 Million	30,000 New	30,000 $2.2 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Silverarc Capital Management, LLC with notifications on news.